Literature DB >> 3154676

Interaction between Ca2+ antagonists and digitalis.

J N Lessem1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3154676     DOI： 10.1007/bf02125729

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  46 in total

1.  [Diltiazem and digoxin interaction. Development of digoxin plasma levels and electrocardiographic parameters in healthy subjects].

Authors:  M Gallet; J F Aupetit; M Lopez; J Manchon; M Lestaevel; J J Lefrançois
Journal:  Arch Mal Coeur Vaiss       Date:  1986-07

2.  Plasma digoxin concentrations in patients with atrial fibrillation and indications for the association with other antiarrhythmic agents.

Authors:  G Cargnelli; F Domeneghetti; M Ferrari; P Malacini; G Roberti
Journal:  Int J Clin Pharmacol Biopharm       Date:  1977-08

Review 3.  Digitalis toxicity.

Authors:  E M Antman; T W Smith
Journal:  Annu Rev Med       Date:  1985       Impact factor: 13.739

4.  Digoxin-diltiazem interaction.

Authors:  Y Oyama; S Fujii; K Kanda; E Akino; H Kawasaki; M Nagata; K Goto
Journal:  Am J Cardiol       Date:  1984-05-15       Impact factor: 2.778

Review 5.  Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction.

Authors:  H O Klein; E Kaplinsky
Journal:  Am J Cardiol       Date:  1982-10       Impact factor: 2.778

6.  Digoxin intoxication induced by verapamil in an uremic patient.

Authors:  A Johannessen; C Rendtorff; S Poulsen
Journal:  Clin Nephrol       Date:  1985-09       Impact factor: 0.975

7.  Lack of effects of diltiazem on digoxin pharmacokinetics.

Authors:  T R Beltrami; J J May; J S Bertino
Journal:  J Clin Pharmacol       Date:  1985 Jul-Aug       Impact factor: 3.126

8.  Pharmacokinetics and metabolism of bepridil.

Authors:  L Z Benet
Journal:  Am J Cardiol       Date:  1985-03-15       Impact factor: 2.778

9.  Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration.

Authors:  K E Pedersen; B D Christiansen; K Kjaer; N A Klitgaard; F Nielsen-Kudsk
Journal:  Clin Pharmacol Ther       Date:  1983-07       Impact factor: 6.875

10.  The comparative effects of verapamil and a new dihydropyridine calcium channel blocker on digoxin pharmacokinetics.

Authors:  B F Johnson; J Wilson; R Marwaha; K Hoch; J Johnson
Journal:  Clin Pharmacol Ther       Date:  1987-07       Impact factor: 6.875
View more
  3 in total

1.  Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.

Authors:  E Yukawa; F Suematu; M Yukawa; M Minemoto; S Ohdo; S Higuchi; Y Goto; T Aoyama
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of vasodilators. Part I.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

Review 3.  How to digitalize and to maintain optimal digoxin levels in congestive heart failure.

Authors:  C Lambert; J L Rouleau
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.